GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Detail and activity of goodwill by segment is presented below (in thousands):



	MMS			ATA			Total
Balance at December 31, 2014:
Goodwill	$	32,434		$	6,698		$	39,132
Accumulated impairment losses	(32,434		)	—			(32,434		)
Goodwill, net of impairment losses	—			6,698			6,698
Current Year Activity:
Currency translation adjustments	—			(62		)	(62		)
Total current year activity	—			(62		)	(62		)
Balance at September 30, 2015:
Goodwill	32,434			6,636			39,070
Accumulated impairment losses	(32,434		)	—			(32,434		)
Goodwill, net of impairment losses	$	—		$	6,636		$	6,636

The major components of intangible assets other than goodwill are as follows (in thousands):



	September 30, 2015			December 31, 2014
Gross amortizable intangible assets:
Technical know-how	$	12,961		$	12,984
Customer lists	9,020			9,047
Land rights	2,730			2,796
Patents, trade names, drawings, and other	4,395			4,345
Total gross amortizable intangible assets	29,106			29,172

Accumulated amortization:
Technical know-how	(6,557		)	(5,730		)
Customer lists	(1,207		)	(871		)
Land rights	(264		)	(228		)
Patents, trade names, drawings, and other	(3,364		)	(3,227		)
Total accumulated amortization	(11,392		)	(10,056		)
Amortizable intangible assets, net	17,714			19,116

Indefinite lived intangible assets:
Trade names	10,797			11,101

Intangible assets other than goodwill, net	$	28,511		$	30,217

Amortization expense related to the definite-lived intangible assets are as follows (in thousands):



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Amortization expense	$	452	$	448	$	1,354	$	1,339

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details